Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma

Oluwaseun B Ogunbona1, Xiaoqi Lin2, Jason L Hornick3

  • 1Department of Pathology and Laboratory Medicine, Emory University Hospital Midtown, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

Abstract

Insights

SMARCA4-deficient non-small cell lung cancers (NSCLCs) show high-grade cytologic features like marked pleomorphism and multinucleation. Awareness of these features aids diagnosis of SMARCA4-deficient NSCLC.

Area of Science:

  • Oncology
  • Cytopathology
  • Molecular Pathology

Background:

  • SMARCA4 (BRG1) inactivation occurs in a subset of non-small cell lung carcinomas (NSCLCs).
  • Cytomorphologic features of SMARCA4-deficient NSCLCs (SMARCA4-dNSCLC) are rarely reported.
  • SMARCA4 is a key component of the switch/sucrose nonfermentable chromatin remodeling complex.

Purpose of the Study:

  • To compare the cytomorphologic and immunophenotypic features of SMARCA4-deficient NSCLCs (SMARCA4-dNSCLC) with SMARCA4-retained NSCLCs (SMARCA4-rNSCLC).
  • To highlight diagnostic clues for SMARCA4-dNSCLC on fine needle aspiration cytology.

Main Methods:

  • Retrospective review of 8 SMARCA4-dNSCLC and 8 SMARCA4-rNSCLC cytology cases.
  • Cytologic evaluation included cell cohesion, nuclear pleomorphism, nucleoli, multinucleation, plasmacytoid morphology, and necrosis.
  • Immunophenotypic analysis included markers for AE1/AE3, thyroid transcription factor-1, Napsin A, p40, p63, and BRG1 expression.

Main Results:

  • SMARCA4-dNSCLC cases predominantly featured loosely cohesive, high-grade epithelioid cells with marked nuclear pleomorphism and prominent nucleoli.
  • Multinucleation (5/8), focal plasmacytoid morphology (6/8), and necrosis (2/8) were observed in SMARCA4-dNSCLC.
  • SMARCA4-rNSCLC cases typically showed cohesive cells with mild to moderate pleomorphism and lacked necrosis; multinucleation was rare (1/8).
  • Both groups lacked thyroid transcription factor-1/Napsin A and p40/p63 expression, but SMARCA4-dNSCLC showed a loss of BRG1 expression.

Conclusions:

  • SMARCA4-dNSCLCs exhibit high-grade cytologic features, including marked pleomorphism, multinucleation, and plasmacytoid morphology.
  • SMARCA4-rNSCLCs generally present with mild to moderate pleomorphism and round to polygonal shapes.
  • Both tumor types characteristically lack expression of common lung adenocarcinoma and squamous cell carcinoma markers.
  • Recognizing these cytomorphologic distinctions is crucial for diagnosing SMARCA4-dNSCLC on fine needle aspiration.

Related Concept Videos